Basics Acumen Pharmaceuticals, Inc. IPO Date: July 1, 2021 Sector: Healthcare Industry: Biotech Market Cap: $62.39M Activated in VL: True Average Daily Range Avg Daily Range: $0.21 | 3.71% Avg Daily Range (30 D): $0.06 | 5.32% Avg Daily Range (90 D): $0.05 | 3.84% Institutional Daily Volume Avg Daily Volume: .33M Avg Daily Volume (30 D): .2M Avg Daily Volume (90 D): .23M Trade Size Avg Trade Size (Sh.): 114 Avg Trade Size (Sh.) (30 D): 159 Avg Trade Size (Sh.) (90 D): 157 Institutional Trades Total Inst.Trades: 56 Avg Inst. Trade: $2.16M Avg Inst. Trade (30 D): $.68M Avg Inst. Trade (90 D): $.68M Avg Inst. Trade Volume: .33M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.29M Avg Closing Trade (30 D): $8.78M Avg Closing Trade (90 D): $8.78M Avg Closing Volume: 525.35K         News Apr 2, 2025 @ 11:00 AM Acumen Pharmaceuticals Showcases pTau217 Trial Scr... Source: N/A Mar 19, 2025 @ 11:00 AM Chlorinated Isopropane Market Set for 4.9% CAGR Gr... Source: Fact.Mr Mar 12, 2025 @ 12:00 PM Acumen Pharmaceuticals to Present During Internati... Source: Acumen Pharmaceuticals, Inc. Mar 10, 2025 @ 8:00 PM Acumen Pharmaceuticals to Participate in Upcoming ... Source: N/A Nov 26, 2024 @ 9:00 PM Acumen Pharmaceuticals to Participate in the 7th A... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-1.71 $-.62 $-1.71 Diluted EPS $-1.71 $-.62 $-1.71 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -102.33M $ -37.15M $ -102.33M Operating Income / Loss $ -114.02M $ -39.6M $ -114.02M Cost of Revenue $ $ $ Net Cash Flow $ -31.26M $ 2.44M $ -31.26M PE Ratio